mit a report on the results of such review to the Di-
rector of the Institute and to the Hormone Disrup-
tion Research Panel established under subsection 
(e). 
‘‘(7) TERMINATION.—The Interagency Commis-
sion shall terminate not later than the end of the 5- 
year fiscal period described in subsection (j)(1). 
‘‘(d) FINANCIAL ASSISTANCE.—The Director of the 
Institute may provide financial assistance and enter into 
grants, contracts, and interagency memoranda of under-
standing to conduct activities under this section. Research 
conducted pursuant to interagency memoranda of under-
standing may be conducted through intramural and extra-
mural agency research programs, subject to appropriate 
scientific peer review. 
‘‘(e) HORMONE DISRUPTION RESEARCH PANEL.— 
‘‘(1) ESTABLISHMENT.—There is established in 
the Institute a Hormone Disruption Research Panel 
(referred to in this subsection as the ‘Panel’). 
‘‘(2) DUTIES.—The Panel shall make rec-
ommendations to the Interagency Commission with 
respect to the duties of the Interagency Commission 
under subsection (c)(1) and advise the Secretary and 
the Director of the Institute with respect to the de-
sign and implementation of the program under sub-
VerDate Nov 24 2008 
01:42 Dec 02, 2009
Jkt 089200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H4160.IH
H4160
smartinez on DSKB9S0YB1PROD with BILLS
section (a), including preparation of solicitations for 
proposals to conduct research under the program. 
‘‘(3) MEMBERSHIP.—The Panel shall be com-
posed of the following: 
‘‘(A) 15 voting members to be appointed 
by the President, in consultation with the Di-
rector of the Institute. 
‘‘(B) Such nonvoting, ex officio members 
as the Director of the Institute determines to 
be appropriate. 
‘‘(4) VOTING
MEMBERS.—Of the 15 voting 
members of the Panel— 
‘‘(A) at least 2 members shall be from en-
vironmental protection organizations; 
‘‘(B) at least 2 members shall be from 
public health and consumer organizations; 
‘‘(C) at least 2 members but not more 
than 7 shall be from industry; 
‘‘(D) at least 1 member shall be from an 
animal welfare organization; and 
‘‘(E) a majority of the members shall be 
selected from among scientists and environ-
mental health professionals who— 
‘‘(i) are not officers or employees of 
the United States; 
VerDate Nov 24 2008 
01:42 Dec 02, 2009
Jkt 089200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H4160.IH
H4160
smartinez on DSKB9S0YB1PROD with BILLS
‘‘(ii) represent multiple disciplines, in-
cluding clinical, basic, public, and ecologi-
cal health sciences; 
‘‘(iii) represent different geographical 
regions of the United States; 
‘‘(iv) are from practice settings, aca-
demic settings, and for-profit or not-for- 
profit research settings; 
‘‘(v) have experience in review of re-
search on endocrine disruption; and 
‘‘(vi) possess a relevant advanced de-
gree from an accredited college or univer-
sity. 
‘‘(5) TERMS.—The members of the Panel shall 
be appointed for an initial term of 3 years and shall 
be eligible for reappointment for 1 additional term 
of 2 years. 
‘‘(6) CHAIRPERSON.—The members of the 
Panel appointed under paragraph (3) shall elect a 
chairperson from among such members. 
‘‘(7) MEETINGS.—The Panel shall meet at the 
call of the chairperson or upon the request of the 
Director of the Institute, but in no case less often 
than once each year. 
VerDate Nov 24 2008 
01:42 Dec 02, 2009
Jkt 089200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H4160.IH
H4160
smartinez on DSKB9S0YB1PROD with BILLS
‘‘(8) ADMINISTRATIVE SUPPORT.—The Institute 
shall provide administrative support to the Panel. 
‘‘(9) TERMINATION.—The Panel shall terminate 
not later than the end of the 5-year fiscal period de-
scribed in subsection (j)(1). 
‘‘(f) SOLICITATION
AND
SELECTION
OF
PRO-
POSALS.— 
‘‘(1) IN GENERAL.—Within 15 months after the 
date of the enactment of the Environmental Hor-
mone Disruption Research Act of 2009, and as often 
thereafter as appropriate, the Director of the Insti-
tute shall, in consultation with the Interagency Com-
mission, solicit and select proposals to conduct ac-
tivities under the program under subsection (a). 
‘‘(2) CONSULTATION
WITH
PANEL.—In pre-
paring solicitations for such proposals, the Director 
of the Institute shall consult with the Hormone Dis-
ruption Research Panel. 
‘‘(3) PEER
REVIEW
PANELS.—Before a pro-
posal to conduct activities under the program under 
subsection (a) may be selected by the Director of the 
Institute, such proposal shall be submitted to, and 
evaluated by, at least one scientific and technical 
peer review panel. 
‘‘(g) REPORTS.— 
VerDate Nov 24 2008 
01:42 Dec 02, 2009
Jkt 089200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H4160.IH
H4160
smartinez on DSKB9S0YB1PROD with BILLS
‘‘(1) REPORT
UPON
COMPLETION
OF
ACTIV-
ITY.—Any person who conducts activities under the 
program under subsection (a) shall, upon completion 
of the activity, submit to the National Academy of 
Sciences, the Interagency Commission, and the Hor-
mone Disruption Research Panel a report summa-
rizing the activities and results thereof. 
‘‘(2) REPORT
TO
INTERAGENCY
COMMISSION 
AND
PANEL.—The Director of the Institute shall 
enter into appropriate arrangements with the Na-
tional Academy of Sciences under which the Acad-
emy shall periodically submit to the Interagency 
Commission and the Hormone Disruption Research 
Panel a report that evaluates the research activities 
under the program under subsection (a). The report 
shall include recommendations to promote the effec-
tive transfer of information derived from such re-
search activities. The Director of the Institute shall 
be responsible for expenses incurred by the Academy 
in connection with the preparation of such reports. 
‘‘(3) REPORT TO CONGRESS.—The Interagency 
Commission, in consultation with the Hormone Dis-
ruption Research Panel, shall submit to the Sec-
retary and the Congress— 
VerDate Nov 24 2008 
01:42 Dec 02, 2009
Jkt 089200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H4160.IH
H4160
smartinez on DSKB9S0YB1PROD with BILLS
‘‘(A) not later than December 31, 2013, a 
report summarizing the progress of the research 
program under subsection (a); and 
‘‘(B) not later than September 30, 2016, a 
final report stating the Interagency Commis-
sion’s findings and conclusions on the effects, if 
any, of hormone-disrupting pollutants in the en-
vironment on human health and remedial ac-
tions, if any, that may be needed to minimize 
any such health effects. 
‘‘(h) CONFLICTS OF INTEREST.—All grants and con-
tracts entered into under this section shall include conflict- 
of-interest provisions that require any person conducting 
a project under this section to disclose any other source 
of funding received by the person to conduct other related 
projects. 
‘‘(i) DEFINITIONS.—For purposes of this section: 
‘‘(1) HORMONE.—The term ‘hormone’ means a 
substance produced in a cell or tissue that triggers 
a biological response. Hormone activity may be local-
ized to the cell in which the substance is produced, 
or may be in nearby or distant tissues or organs. 
‘‘(2) HORMONE-DISRUPTING.—The term ‘hor-
mone-disrupting’ means producing effects similar to 
those of naturally occurring hormones or interfering 
VerDate Nov 24 2008 
01:42 Dec 02, 2009
Jkt 089200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H4160.IH
H4160
smartinez on DSKB9S0YB1PROD with BILLS
with hormone signaling or hormone interaction with 
receptors. 
‘‘(3) HORMONE DISRUPTION.—The term ‘hor-
mone disruption’ means interference with the syn-
thesis, secretion, transport, binding, action, or elimi-
nation of natural hormones in the body that are re-
sponsible for the maintenance of homeostasis, repro-
duction, development, function, or behavior. 
‘‘(j) AUTHORIZATION OF APPROPRIATIONS.— 
‘‘(1) GENERAL
AUTHORIZATION.—There are 
authorized to be appropriated such sums as may be 
necessary for the 5-fiscal-year period beginning with 
fiscal year 2011 to carry out this section. Amounts 
appropriated pursuant to this paragraph shall re-
main available until expended. 
‘‘(2) RESTRICTIONS ON USE OF FUNDS.— 
‘‘(A) CONSTRUCTION
AND
REHABILITA-
TION
OF
FACILITIES
AND
EQUIPMENT.—Not 
more than 0.5 percent of the funds made avail-
able under this section may be used for the con-
struction or rehabilitation of facilities or fixed 
equipment. 
‘‘(B) ADMINISTRATIVE EXPENSES OF THE 
DIRECTOR.—Of the total amount of funds made 
available under this section for any fiscal year, 
VerDate Nov 24 2008 
01:42 Dec 02, 2009
Jkt 089200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H4160.IH
H4160
smartinez on DSKB9S0YB1PROD with BILLS
not more than 2 percent of such funds may be 
used for administrative expenses of the Director 
of the Institute in carrying out this section. 
‘‘(C) PUBLIC
OUTREACH.—Of the total 
amount of funds made available under this sec-
tion for any fiscal year, at least 1 percent, but 
not more than 5 percent, shall be used for out-
reach to the public concerning the activities and 
results of the program.’’. 
SEC. 4. COMMITTEE HEARING ON IMPLEMENTATION. 
(a) IN GENERAL.—The Committee on Energy and 
Commerce of the House of Representatives shall hold a 
hearing on the implementation by the Director of the Na-
tional Institute of Environmental Health Sciences of sec-
tion 463C of the Public Health Service Act, as added by 
section 3 of this Act. 
(b) EXERCISE OF RULEMAKING AUTHORITY.—Sub-
section (a)— 
(1) is enacted as an exercise of the rulemaking 
power of the House of Representatives and, as 
such— 
(A) shall be considered as part of the rules 
of the House; and 
VerDate Nov 24 2008 
01:42 Dec 02, 2009
Jkt 089200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H4160.IH
H4160
smartinez on DSKB9S0YB1PROD with BILLS
(B) shall supersede any other rule of the 
House only to the extent that rule is incon-
sistent therewith; and 
(2) is enacted with full recognition of the con-
stitutional right of the House to change such rules 
(so far as relating to the procedure in the House) 
at any time, in the same manner, and to the same 
extent as in the case of any other rule of the House. 
Æ 
VerDate Nov 24 2008 
01:42 Dec 02, 2009
Jkt 089200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6301
E:\BILLS\H4160.IH
H4160
smartinez on DSKB9S0YB1PROD with BILLS